Genmab (NASDAQ:GMAB) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.44 by 88.64 percent. This is a 94.12 percent decrease over earnings of $0.85 per share from the same period last year. The company reported quarterly sales of $1.058 billion which missed the analyst consensus estimate of $4.401 billion by 75.96 percent. This is a 14.81 percent increase over sales of $921.559 million the same period last year.